ESOPMay 1, 2026, 04:31 PM
ORIC Pharmaceuticals Grants 216K Stock Options, 35K RSUs to New Hires
AI Summary
ORIC Pharmaceuticals, Inc. announced that it granted a total of 216,000 non-qualified stock options and 35,000 restricted stock units to four new non-executive employees on May 1, 2026. These inducement grants were made pursuant to the company's 2022 Inducement Equity Incentive Plan. The grants are subject to specific vesting schedules, with stock options vesting over approximately four years and RSUs over three years, contingent on continued employment.
Key Highlights
- ORIC Pharmaceuticals granted 216,000 non-qualified stock options.
- The company also granted 35,000 restricted stock units (RSUs).
- Grants were made to four new non-executive employees.
- Stock options vest 25% after one year, then 1/36th monthly thereafter.
- Restricted stock units vest one-third annually over three years.
- Grants were approved by the Compensation Committee under Nasdaq Rule 5635(c)(4).
Price Impact
More from ORIC